Clinical application of two class 1 new drugs in Guangdong dongyangguang Pharmaceutical Co., Ltd

According to the website of the State Food and drug administration, Guangdong dongyangguang Pharmaceutical Co., Ltd applied for the clinical approval of two class 1 new drugs, respectively, laelotinib mesylate capsule and imitavir phosphate capsule, for the treatment of tumor and influenza respectively There is no domestic manufacturer of the above-mentioned drugs, and only dongyangguang Pharmaceutical Co., Ltd has applied for clinical application Guangdong dongyangguang Pharmaceutical Co., Ltd is a subsidiary of dongyangguang aluminum Dongyangguang aluminum is mainly engaged in large-scale professional hydrophilic foil production enterprises The pharmaceutical industry is one of the company's core businesses Yichang Changjiang pharmaceutical, another subsidiary of dongyangguang aluminum, is one of the domestic manufacturers of oseltamivir (Tamiflu) Oseltamivir can be used for the early treatment of h7n9 avian influenza virus During the SARS in 2009, the company obtained a large number of government purchase orders.